Pimecrolimus 1% cream for perianal atopic dermatitis [10]

British Journal of Dermatology

Volumn 152, Issue 1, 2005, Pages 186-187

  Kreuter, A ^a   Hochdorfer, B ^a   Altmeyer, P ^a   Gambichler, T ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b OLDCHURCH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; EMOLLIENT AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROCORTISONE; PIMECROLIMUS; GLUCOCORTICOID; IMMUNOGLOBULIN E; TACROLIMUS;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; BODY DISTRIBUTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RELAPSE; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; ALLERGIC RHINITIS; ASTHMA; CHRONIC INFLAMMATION; DERMATITIS; ERYTHEMA; PATHOGENESIS; PERIANAL ATOPIC DERMATITIS; PREVALENCE; PRURITUS; SKIN INFLAMMATION; TOPICAL TREATMENT;

ADULT; AGED; ANAL CANAL; CALCINEURIN; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; TACROLIMUS;

EID: 13244288016     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06327.x     Document Type: Letter

References (6)

1. Eichenfield LF, Lucky AW, Boguniewicz M et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002; 46:495-504.
2. Ruzicka T, Bieber T, Schopf E et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 18:816-21.
3. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.):44-7.
4. Gupta AK, Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003; 17:493-503.
5. Mrowietz U, Graeber M, Braeutigam M et al. The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion Br J Dermatol 1998; 139:992-6.
6. Thaci D, Steinmeyer K, Ebelin ME et al. Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure, is well tolerated, safe, and effective. Dermatology 2003; 207:37-42.